Quo Vadis, Specificity?

See allHide authors and affiliations

Science  11 Jan 2008:
Vol. 319, Issue 5860, pp. 164-165
DOI: 10.1126/science.1153713

You are currently viewing the summary.

View Full Text


Mutations in cancer cells can give rise to tumor-specific antigens, but abnormal processing of normal molecules in these cells can also elicit an immune response.